takedaoncology.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Takeda |
| Description | Close Menu Takeda Oncology Takeda Oncology Decades of Leadership in Oncology Explore Our Approach Oncology News View All Takeda Awards More Than $650,000 |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 217.114.85.70 |
| Location | Sweden |
Related Websites
| Site | Rank |
More to Explore
takedaoncology.com Valuation
|
US$37,872,228
Last updated: 2023-04-26 20:54:22
takedaoncology.com has Semrush global rank of 279,474. takedaoncology.com has an estimated worth of US$ 37,872,228, based on its estimated Ads revenue. takedaoncology.com receives approximately 4,369,873 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.70. According to SiteAdvisor, takedaoncology.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$37,872,228 |
| Daily Ads Revenue | US$34,959 |
| Monthly Ads Revenue | US$1,048,770 |
| Yearly Ads Revenue | US$12,585,233 |
| Daily Unique Visitors | 291,325 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| takedaoncology.com. | A | 298 | IP: 217.114.85.70 |
| takedaoncology.com. | NS | 86400 | NS Record: ns-1041.awsdns-02.org. |
| takedaoncology.com. | NS | 86400 | NS Record: ns-1583.awsdns-05.co.uk. |
| takedaoncology.com. | NS | 86400 | NS Record: ns-396.awsdns-49.com. |
| takedaoncology.com. | NS | 86400 | NS Record: ns-701.awsdns-23.net. |
| takedaoncology.com. | MX | 300 | MX Record: 10 gate-mlnm-10.mpi.com. |
| takedaoncology.com. | MX | 300 | MX Record: 20 gate-mlnm-20.mpi.com. |
| takedaoncology.com. | TXT | 300 | TXT Record: ukcmrsb7i480o9ia8o7n0ni4ge |
| takedaoncology.com. | TXT | 300 | TXT Record: v=spf1 include:spf-00297f01.pphosted.com include:spf.protection.outlook.com ~all |
| takedaoncology.com. | TXT | 300 | TXT Record: google-site-verification=owyP-O3x2z9Ny6O1b3NKB8B-WV5k_azFy9dnsOm7r3I |
HtmlToTextCheckTime:2023-04-26 20:54:22
| Close Menu Takeda Oncology Takeda Oncology Decades of Leadership in Oncology Explore Our Approach Oncology News View All Takeda Awards More Than $650,000 to Community Organizations through Health Equity Grant Program calendar March 29, 2023 Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib, a Highly Selective, Oral VEGFR1/2/3 Tyrosine Kinase Inhibitor calendar January 23, 2023 Takeda’s EXKIVITY® (mobocertinib) Receives Approval from the NMPA of China, Becoming the First and Only Therapy Available for Patients with EGFR Exon20 Insertion+ NSCLC calendar January 11, 2023 Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases calendar December 7, 2022 Oncology Pipeline Discovering and developing innovative therapies to deliver potentially transformative treatments Explore Pipeline About Takeda Oncology Science Medicines Patients Investors |
HTTP Headers
HTTP/1.0 301 Moved Permanently Location: http://www.takedaoncology.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Date: Wed, 20 Oct 2021 07:47:38 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 154 Connection: close Location: https://www.takedaoncology.com/ CF-Cache-Status: MISS Expires: Wed, 20 Oct 2021 08:07:38 GMT Cache-Control: public, max-age=1200 Server: cloudflare CF-RAY: 6a10a3a22bd64941-STL HTTP/2 200 date: Wed, 20 Oct 2021 07:47:38 GMT content-type: text/html; charset=utf-8 cache-control: public, max-age=1200 pragma: no-cache expires: Wed, 20 Oct 2021 08:07:38 GMT vary: Accept-Encoding strict-transport-security: max-age=31536000; includeSubDomains; preload x-content-type-options: nosniff x-xss-protection: 1 request-context: appId=cid-v1:e0c4f277-7b27-4b4c-9e02-2c0635530452 access-control-expose-headers: Request-Context cf-cache-status: EXPIRED expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a10a3a4faee2928-ORD |
takedaoncology.com Whois Information
Domain Name: TAKEDAONCOLOGY.COM Registry Domain ID: 1041996584_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-06-17T05:09:46Z Creation Date: 2007-06-21T21:17:25Z Registry Expiry Date: 2022-06-21T21:17:25Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1041.AWSDNS-02.ORG Name Server: NS-1583.AWSDNS-05.CO.UK Name Server: NS-396.AWSDNS-49.COM Name Server: NS-701.AWSDNS-23.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-08T15:57:16Z <<< |